Literature DB >> 35218811

Quantitative analysis of breast cancer tissue composition and associations with tumor subtype.

Linnea T Olsson1, Lindsay A Williams2, Bentley R Midkiff3, Erin L Kirk1, Melissa A Troester4, Benjamin C Calhoun5.   

Abstract

The tumor microenvironment is an important determinant of breast cancer progression, but standard methods for describing the tumor microenvironment are lacking. Measures of microenvironment composition such as stromal area and immune infiltrate are labor-intensive and few large studies have systematically collected this data. However, digital histologic approaches are becoming more widely available, allowing high-throughput, quantitative estimation. We applied such methods to tissue microarrays of tumors from 1687 women (mean 4 cores per case) in the Carolina Breast Cancer Study Phase 3. Tumor composition was quantified as percentage of epithelium, stroma, adipose, and lymphocytic infiltrate (with the latter as presence/absence using a ≥1% cutoff). Composition proportions and presence/absence were evaluated in association with clinical and molecular features of breast cancer (intrinsic subtype and RNA-based risk of recurrence [ROR] scores) using multivariable linear and logistic regression. Lower stromal content was associated with aggressive tumor phenotypes, including triple-negative (31.1% vs. 41.6% in HR+/HER2-; RFD [95% CI]: -10.5%, [-13.1, -7.9]), Basal-like subtypes (29.0% vs. 44.0% in Luminal A; RFD [95% CI]: -14.9%, [-17.8, -12.0]), and high RNA-based PAM50 ROR scores (27.6% vs. 48.1% in ROR low; RFD [95% CI]: -20.5%, [24.3, 16.7]), after adjusting for age and race. HER2+ tumors also had lower stromal content, particularly among RNA-based HER2-enriched (35.2% vs. 44.0% in Luminal A; RFD [95% CI]: -8.8%, [-13.8, -3.8]). Similar associations were observed between immune infiltrate and tumor phenotypes. Quantitative digital image analysis of the breast cancer microenvironment showed significant associations with demographic characteristics and biological indicators of aggressive behavior.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; Digital histology; Microenvironment; Pathology; Stroma; Tumor-infiltrating lymphocytes (TILs)

Mesh:

Substances:

Year:  2022        PMID: 35218811      PMCID: PMC9050931          DOI: 10.1016/j.humpath.2022.02.013

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.526


  24 in total

1.  Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.

Authors:  Andrew H Beck; Ankur R Sangoi; Samuel Leung; Robert J Marinelli; Torsten O Nielsen; Marc J van de Vijver; Robert B West; Matt van de Rijn; Daphne Koller
Journal:  Sci Transl Med       Date:  2011-11-09       Impact factor: 17.956

2.  A Deep Convolutional Neural Network for segmenting and classifying epithelial and stromal regions in histopathological images.

Authors:  Jun Xu; Xiaofei Luo; Guanhao Wang; Hannah Gilmore; Anant Madabhushi
Journal:  Neurocomputing       Date:  2016-02-17       Impact factor: 5.719

Review 3.  Digital imaging in pathology: whole-slide imaging and beyond.

Authors:  Farzad Ghaznavi; Andrew Evans; Anant Madabhushi; Michael Feldman
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

4.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

5.  Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma.

Authors:  Rupninder Sandhu; Lynn Chollet-Hinton; Erin L Kirk; Bentley Midkiff; Melissa A Troester
Journal:  Hum Pathol       Date:  2015-10-23       Impact factor: 3.466

6.  Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types.

Authors:  Michael D Iglesia; Joel S Parker; Katherine A Hoadley; Jonathan S Serody; Charles M Perou; Benjamin G Vincent
Journal:  J Natl Cancer Inst       Date:  2016-06-22       Impact factor: 13.506

7.  Interobserver variability in breast carcinoma grading results in prognostic stage differences.

Authors:  Kimmie Rabe; Olivia L Snir; Veerle Bossuyt; Malini Harigopal; Romulo Celli; Emily S Reisenbichler
Journal:  Hum Pathol       Date:  2019-10-23       Impact factor: 3.466

8.  Epithelial p53 Status Modifies Stromal-Epithelial Interactions During Basal-Like Breast Carcinogenesis.

Authors:  Ashley M Fuller; Lin Yang; Alina M Hamilton; Jason R Pirone; Amy L Oldenburg; Melissa A Troester
Journal:  J Mammary Gland Biol Neoplasia       Date:  2021-01-13       Impact factor: 2.698

9.  Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast.

Authors:  Lynn Chollet-Hinton; Samantha Puvanesarajah; Rupninder Sandhu; Erin L Kirk; Bentley R Midkiff; Karthik Ghosh; Kathleen R Brandt; Christopher G Scott; Gretchen L Gierach; Mark E Sherman; Celine M Vachon; Melissa A Troester
Journal:  Mod Pathol       Date:  2018-02-20       Impact factor: 7.842

10.  Digital Assessment of Stained Breast Tissue Images for Comprehensive Tumor and Microenvironment Analysis.

Authors:  Shachi Mittal; Catalin Stoean; Andre Kajdacsy-Balla; Rohit Bhargava
Journal:  Front Bioeng Biotechnol       Date:  2019-10-01
View more
  1 in total

1.  The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.

Authors:  Melissa A Troester; Katherine A Hoadley; Alina M Hamilton; Amber N Hurson; Linnea T Olsson; Andrea Walens; Joseph Nsonwu-Farley; Erin L Kirk; Yara Abdou; Stephanie M Downs-Canner; Jonathan S Serody; Charles M Perou; Benjamin C Calhoun
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.